Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

ArteraAI

start up
United States - Los Altos, California
  • 27/03/2023
  • Unknown
  • $90,000,000

Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer.

Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.


Related People

Andre EstevaCo Founder

Andre Esteva United States - Los Altos, California

Homepage: andreesteva.com
Publications: andreesteva.com/scholar.html
Twitter: https://twitter.com/andreesteva

Andre Esteva is a researcher and entrepreneur in medical artificial intelligence. He currently serves as CEO of Artera, and was previously Head of Medical AI at Salesforce Research. He has worked at Google Research, Sandia National Labs, GE Healthcare, and has co-founded four companies.

His research efforts have largely focused on medical AI diagnostics and precision medicine. His publications have made the covers of Nature and Nature Medicine, and have been featured in Cell, The Lancet, NeurIPS, and similar venues. These works have been widely covered by the WSJ, Fortune, BBC, The Economist, and hundreds of other news outlets.

He obtained his PhD in Artificial Intelligence at Stanford, where he worked with Jeff Dean, Eric Topol, Sebastian Thrun, Stephen Boyd, and Fei-Fei Li. His research was in deep learning and computer vision, with applications built for dermatology, drug screening, neuroscience, and psychiatry. He finished undergraduate degrees with highest honors in Electrical Engineering and Pure Math from UT-Austin and was awarded Engineering Valedictorian (formally, the Outstanding Scholar-Leader Award).